Global Tech Innovator in China will be held on 22nd July. Judges will select the winning enterprises to represent China to participate in the global final event in November where they will compete with outstanding enterprises from all over the world for the global crown.
Finalists
Beth Bioinformatics
Beth Bioinformatics provides a series of innovative solutions for pharmaceutical companies to empower the development of new and better vaccines. BethBio's technologies such as virus evolution prediction, vaccine effectiveness evaluation in-silico and codon deoptimization, are applicable to all kinds of vaccine technology platform and many viruses including SARS-CoV-2, Influenza and more.
Cellomics
Cellomics which is a national high-tech enterprise is committed to providing a full range of precision diagnostic products and services for cancer screening and detection. Cellomics develops and has launched the market-leading "Circulating Tumor Cell Enrichment and Detection", "Chipless Digital PCR", "Single-cell NGS Sequencing" technology platforms and corresponding IVD kits, providing clinical and research markets with products and services for cancer early screening, detection, companion diagnosis, disease monitoring, and personalized treatment.
MixCare Health
MixCare Health is a leading digital health platform that improves access and quality of healthcare. Our vision is to democratize and digitalize healthcare in Asia Pacific.
We provide a B2B solution to Insurers and enterprise to get access to vendors, and enhance digital capability through services that are customized and white-labelled. We help these clients improve engagement and build a more cost efficient health insurance product and employee benefit portal. MixCare is trusted by more than 15,000 consumers in Hong Kong, 3000 medical & wellness vendors services.
Nosecare Technology
Nosecare Technology (Beijing) Co., Ltd. is a technology company focusing on the research and development, production and sales of nasal medical devices, providing more effective, safe and economical clinical solutions for nasal diseases. The core product is nasal stent, the effectiveness, comfort and safety are far higher than the replaced medical devices. There is no domestic manufacturer to apply for approval. The threshold is high, and the company has a longer window period of high profit.
Vision Medicals
Founded in 2018, Vision Medicals was certificated by the superior government as a new-high tech enterprise，focusing on the field of genetic diagnosis and infection precision medicine, building an AI diagnosis system for infectious diseases based on genomics, imageomics and EMR, and providing comprehensive solutions for accurate diagnosis of infection for clinical practice.
BRIdata
Beijing Mingshu Data Technology Co., Ltd. was founded in 2017, focusing on the field of infrastructure investment and financing, creating a new model of "Data + Software + Consulting". The independently developed investment and financing data platform and ApaaS low code development cloud platform provide government departments, social capital investors and financial institutions with full lifecycle digital management, data services, risk management Performance management and whole process consulting services. The shareholder Longyuan construction (600491) is a listed company with special qualification for general contracting of real estate construction.
Dongan
Dongan is the leader in digital NPL management (founded 2018). By focusing on digital-first and technology innovation, Dongan makes NPL management businesses with superior debt collection results. Powered by data and technology and asset analyze, our system reaches out to debtor with the right information at the right time so that they are empowered to take the steps necessary to fulfill their financial responsibility. Our work recover billions in lost revenue, also contributes to common prosperity for society.
HashSTACS
HashSTACS China is a Fintech company founded by blockchain technology experts and financial industry experts. We are dedicated to serving customers of licensed financial institutions and government enterprises, providing digital infrastructure and solutions services for digital transformation to customers.
Yuanbao Tech
Yuanbao Tech is a national high-tech enterprise and a vanguard in the domestic cybersecurity insurance field in China. Our work is found on the quantitative risk assessment model and platform for independent intellectual property rights. We help companies build their proactive risk management solutions with "insurance + risk management + service".
With our innovation, we revolutionized the domestic cybersecurity industry by combining risk scenarios and insurance coverage. We quantify corporate cyber risks, provides risk assessment, model research and development, as well as technical services to insurance and reinsurance companies. We also provide proactive risk monitoring and early warning services to enterprises. Our work aims to help companies form a closed loop of risk management.
Judges
Daniel Chan
Daniel Chan, National Head of Technology, Media and Telecommunications (TMT) sector, is leading and supporting KPMG China network across all lines of service – Audit, Tax as well as Advisory - to provide one-stop professional solutions and services to companies in the TMT sector. Daniel is a practising member of both the Hong Kong Institute of Certified Public Accountants and the Certified Practicing Accountants Australia. He has been working in KPMG for over 30 years and has extensive experience in providing audit services to TMT clients in Mainland China and Hong Kong.
Jack Kong
Mr. Jack Kong is currently the Venture Partner at Beyond Ventures, a Hong Kong based venture capital firm founded in 2017. He is responsible for actively sourcing and identifying suitable investment opportunities for the firm, scouting excellent startups by working closely with fund of funds (“FoF”) and other venture capital funds, participating in various fundraising activities, and maintaining good relationships with stakeholders in the industry. He also supports a family office that manages up to US$250 million in direct investments, as well as a FoF portfolio of US$600 million.
Archie Fong
Mr. Archie Fong currently works as Head of Healthcare and Corporate Finance for Ping An of China Capital (HK). He formerly worked as general manager of Yue Xiu Capital and Head of Corporate Finance for China Industrial Securities International, responsible for investment banking businesses. He accumulated over 22 years of experience in investment, financing and corporate management. He handled tremendous projects including direct investment, IPO, M&A, equity and debt financing with total deal sizes close to US100 billion. He assisted his served investment bank in securing no.1 IPO fund raising in HK and the globe. Mr. Fong actively cooperates with the governments and professional associations to organise financial topic related forums, activities and policy consultation works. He also contributes to the development of medical and healthcare industries in Greater China region.
Qinchao, Cherry Lu
- Cherry founded Redhill Capital in 2018. Redhill Capital is a dedicated healthcare fund. It is currently managing 4 funds and invested more than 40 deals, quite some of which have become the sub sector leaders, e.g. cofoe (301087), Breo (688793), etc.
- Before 2018, Cherry had worked nearly 13 years at Sequoia Capital China, from analyst up to partner in Sequoia with brilliant proven track record. Prior to Sequoia, her working experience crossed over from medical university Administration to Sales & Marketing for different medical products.
- Comprehensive Educational Background: Bachelor of Clinical Medicine (MD equivalent) from Tongji Medical University, MBA from The Chinese University of HK, EMBA from Cheung Kong Graduate School of Business. Tsinghua PBCSF Healthcare Industry Leader Course, etc.
- Industry recognition: Forbes 2021/2020/2018 Top 25 Female Venture Capitalists in China ; Chinese Venture 2020/2019/2018 Top 30 Outstanding Innovators in Equity Investment; China FOF Alliance 2021, 2020 Best Female Investors; Zero2ipo 2021 Top50 Female Investors; Instructor for Merck China Innovation Center; FMBA Instructor at Cheung Kong Graduate School of Business, etc.